论文部分内容阅读
目的对纳米碳淋巴示踪剂应用于腹腔镜结直肠癌手术的应用价值进行探讨分析。方法 50例行腹腔镜结直肠癌根治术治疗的结直肠癌患者,根据术前是否应用淋巴示踪剂标记分为实验组(26例)和对照组(24例)。实验组术前应用淋巴示踪剂,对照组未使用淋巴示踪剂。比较两组临床疗效。结果两组手术时间、淋巴结转移枚数比较差异无统计学意义(P>0.05);实验组平均淋巴结检出枚数以及微小淋巴结检出数量明显多于对照组(P<0.05)。结论对行腹腔镜结直肠癌手术治疗的患者术中应用纳米碳淋巴示踪剂,临床应用价值较高。
Objective To investigate the application value of nanocarbon lymphatic tracer in laparoscopic colorectal cancer surgery. Methods Fifty patients with colorectal cancer undergoing laparoscopic radical resection of colorectal cancer were divided into experimental group (n = 26) and control group (n = 24) according to whether preoperative lymphatic tracer was used or not. Lymph tracer was used in the experimental group before operation and no lymph tracer was used in the control group. The clinical efficacy of the two groups were compared. Results There was no significant difference in the number of lymph node metastasis between the two groups (P> 0.05). The number of detected lymph nodes and the number of detected lymph nodes in the experimental group were significantly more than those in the control group (P <0.05). Conclusion The application of nanocarbon lymphatic tracer in patients undergoing laparoscopic surgery for colorectal cancer has a high clinical value.